A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Illumina Regeneron Alliance Targets Multiomics And Raises Valuation Questions - Yahoo Finance UK
Illumina Regeneron Alliance Targets Multiomics And Raises Valuation Questions - Yahoo Finance UK
Genomics, multiomics, and spatial biology at AGBT 2026 - C&EN
Genomics, multiomics, and spatial biology at AGBT 2026 - C&EN
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering - PR Newswire
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering - PR Newswire
Illumina (ILMN) Gaining from Stronger Than Expected Results - Insider Monkey
Illumina (ILMN) Gaining from Stronger Than Expected Results - Insider Monkey
How Illumina Inc. (ILMN) Affects Rotational Strategy Timing - Stock Traders Daily
How Illumina Inc. (ILMN) Affects Rotational Strategy Timing - Stock Traders Daily
Elo Mutual Pension Insurance Co Makes New Investment in Illumina, Inc. $ILMN - MarketBeat
Elo Mutual Pension Insurance Co Makes New Investment in Illumina, Inc. $ILMN - MarketBeat
ARK Investment Management Boosts Stake in Illumina - National Today
ARK Investment Management Boosts Stake in Illumina - National Today
ARK Investment Management LLC Has $139.41 Million Position in Illumina, Inc. $ILMN - MarketBeat
ARK Investment Management LLC Has $139.41 Million Position in Illumina, Inc. $ILMN - MarketBeat
Why Illumina (ILMN) is a Top Growth Stock for the Long-Term - Nasdaq
Why Illumina (ILMN) is a Top Growth Stock for the Long-Term - Nasdaq
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Is Illumina’s (ILMN) TruPath Rare Disease Push Reframing Its Clinical Sequencing Investment Narrative? - simplywall.st
Is Illumina’s (ILMN) TruPath Rare Disease Push Reframing Its Clinical Sequencing Investment Narrative? - simplywall.st
Cardiogenetic testing at scale: the TruGenome Cardiovascular Disease Test and CardioSeq Clinical Trial - Illumina
Cardiogenetic testing at scale: the TruGenome Cardiovascular Disease Test and CardioSeq Clinical Trial - Illumina
Illumina Inc (ILMN) Trading Down 2.84% on Mar 2 - GuruFocus
Illumina Inc (ILMN) Trading Down 2.84% on Mar 2 - GuruFocus
Why Illumina (ILMN) Is Up 14.3% After Launching TruPath Genome And Expanding Rare-Disease Sequencing - Yahoo Finance
Why Illumina (ILMN) Is Up 14.3% After Launching TruPath Genome And Expanding Rare-Disease Sequencing - Yahoo Finance
Illumina Deepens Clinical Genomics Role With TruPath Genome And FSU Deal - simplywall.st
Illumina Deepens Clinical Genomics Role With TruPath Genome And FSU Deal - simplywall.st
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page